U.S. Other Utilities Stock News

Edgewise Therapeutics (EWTX) has been attracting attention after two significant updates: progress on several late-stage clinical trials and a key leadership change as the company prepares to shift toward commercialization. Investors are watching these developments closely. See our latest analysis for Edgewise Therapeutics. After a stretch of underwhelming results earlier this year, Edgewise Therapeutics’ recent momentum stands out: the company posted a 44% one-month share price return and a...

ONE Gas, Inc. announced that John W. Gibson will retire as board chair following the company's Annual Meeting in May 2026, with Deborah A.P. Hersman set to assume the role effective May 21, 2026. Hersman's appointment, following a thorough succession planning process, highlights an emphasis on board leadership with deep expertise in governance, safety, and public policy. We'll explore how this planned board transition, focused on experienced governance, could shape ONE Gas's overall...

Avantor recently announced the appointment of Mary Blenn as Executive Vice President and Chief Operating Officer, placing her in charge of manufacturing and supply chain operations as of November 10, 2025. Concurrently, Avantor faces heightened legal scrutiny as class action lawsuits and shareholder investigations surface, alleging misrepresentations about the company’s competitive positioning and potential breaches of fiduciary duty. We’ll explore how these legal developments could...

Schneider National recently introduced Fast Track, a premium shipping solution designed to meet time-sensitive and high-service freight needs by integrating their truckload and intermodal assets with prioritized rail partnerships across major U.S. and Mexico lanes. This service promises shippers truck-like reliability with intermodal cost efficiencies, offering faster transit times, enhanced security, and high on-time performance levels proven in demanding automotive supply chains. We'll...

Griffon (GFF) has seen its stock move largely in line with broader trends, reflecting shifting momentum over the past month. Recent trading activity gives investors a new angle to assess its long-term prospects. See our latest analysis for Griffon. After climbing for several years, Griffon's momentum has cooled recently. The company has a one-year total shareholder return of -11.3% and a year-to-date share price return of -7.1%. Still, its five-year total return stands out, showing...

Germany recently announced that its Navy has selected Lockheed Martin Canada’s CMS 330 combat management system in a deal valued at more than C$1 billion, further expanding Lockheed Martin's global naval presence. This contract win highlights both the increasing international demand for advanced defense technology and Lockheed Martin's ability to secure high-value government partnerships outside its core U.S. market. We'll now explore how landing the German Navy contract enhances Lockheed...

Realty Income Corporation recently closed a £900 million Sterling-denominated unsecured term loan, with proceeds used to refinance existing debt and pre-fund future maturities, while concurrently executing variable-to-fixed interest rate swaps to lock in a 4.3% interest rate. This proactive step in capital management highlights Realty Income’s focus on strengthening its financial flexibility as it expands its growth initiatives in asset management and debt financing. We’ll explore how Realty...

Beam Therapeutics recently presented at the Jefferies London Healthcare Conference, providing updates on its pipeline progress and financial position, and highlighted robust advancement in pivotal clinical trials for genetic diseases such as alpha-1 antitrypsin deficiency and sickle cell disease. Notably, Beam reported a strengthened cash position of US$1.1 billion, expected to fund its clinical programs into 2028, alongside regulatory discussions that could accelerate gene editing...

NuScale Power recently reported third quarter results with revenue of US$8.24 million but a substantially higher net loss of US$273.32 million, and the company also announced a US$750 million at-the-market equity offering. Significant institutional and insider share sales have accompanied analyst downgrades, raising questions about the company’s outlook amid ongoing project delays and financial pressures. We'll explore how disappointing quarterly results and rising funding needs affect...

First Financial Bancorp. recently completed a US$300 million fixed-to-floating rate junior subordinated unsecured notes offering due December 2035, with the bonds callable and issued at 100% of principal, carrying a 1.25% discount per security and a variable coupon rate. This fixed-income transaction highlights the company's ability to access substantial long-term capital, potentially supporting future growth initiatives and strengthening its funding strategy amid evolving market and...

Jack Henry & Associates (JKHY) stock has caught the attention of investors recently, with its share price edging up in the past month after a quieter stretch. The company's performance continues to invite questions about its current valuation and future growth potential. See our latest analysis for Jack Henry & Associates. Jack Henry & Associates has reversed some earlier weakness with a 1-month share price return of 5.72%. Although momentum has improved recently, the total shareholder return...

Abercrombie & Fitch (ANF) shares have experienced ups and downs over the past few months. The stock has moved modestly higher month to date despite a challenging retail environment. Investors watching ANF are weighing its performance trends as well as broader sector pressures. See our latest analysis for Abercrombie & Fitch. Abercrombie & Fitch’s share price has pulled back significantly from its highs, but that is after an incredible bull run over the last few years. While this year’s share...

On November 17, 2025, Trip.com Group reported its third quarter results, showing revenue of CNY18.34 billion and net income of CNY19.89 billion, both up from a year ago. A key highlight was the very large year-over-year growth in TripGenie AI tool users, which management credits for improving customer experience and operational efficiency in a period of robust travel demand. We’ll examine how Trip.com Group’s enhanced AI-driven offerings and strong earnings performance influence its outlook...

Avista (AVA) shares have shown a measured upward trend over the past month, climbing just over 6% despite a mostly stable news environment. This movement may pique the interest of investors assessing utilities stocks. See our latest analysis for Avista. Avista’s recent 30-day share price return of 6.4% follows a solid year-to-date climb and steady gains over the last 90 days, suggesting gradually building momentum. Looking further out, investors have enjoyed a 10.97% total shareholder return...

McKesson Corporation recently reported strong second-quarter results, with sales rising to US$103.15 billion and net income reaching US$1.11 billion, driven by increased prescription volumes and expanded oncology and multispecialty distribution. The company also raised its adjusted earnings guidance for Fiscal 2026, signaling confidence in ongoing momentum across its oncology, multispecialty, and biopharma services segments. We'll assess how the raised earnings outlook, supported by record...

Novavax (NVAX) shares have seen recent movement, catching the attention of investors looking to understand what is driving the change. Over the past month, the stock is down 25%, prompting questions about underlying trends in the business. See our latest analysis for Novavax. Looking beyond the past month’s slide, Novavax shares have been under pressure for most of the past year, with a 1-year total shareholder return of -18.5% and an even steeper drop over the longer term. Recent declines...

Earlier this month, Rivian Automotive faced heightened scrutiny after both its CEO, Robert J. Scaringe, and Soros Fund Management divested significant portions of their holdings, coinciding with investor concerns over expiring EV tax credits and future demand. This wave of insider and prominent institutional selling has intensified market attention on Rivian’s financial health and long-term growth strategy within a more challenging electric vehicle market. With CEO stock sales underscoring...

Merit Medical Systems recently announced positive long-term clinical results for its WRAPSODY Cell-Impermeable Endoprosthesis (CIE) presented at the VIVA conference, while also disclosing that the Centers for Medicare & Medicaid Services has deferred its decision on a key reimbursement application until at least January 2027. This combination of promising clinical trial outcomes and a significant regulatory delay may affect expectations surrounding future adoption and commercial growth for...

In the past week, Strategy Inc disclosed a major purchase of 8,178 bitcoin valued at approximately $835.6 million, financed by a recent €620 million preferred stock issuance. This substantial addition raised Strategy's bitcoin holdings to nearly 650,000 BTC, highlighting both the company's considerable exposure to digital assets and the market scrutiny over its leveraged approach. We'll examine how Strategy’s commitment to expanding its bitcoin reserves shapes the company’s overall...

Madison Square Garden Entertainment recently reported first-quarter fiscal 2026 earnings, showing revenue growth to US$158.26 million from US$138.71 million last year, alongside a widening net loss and the departure of its Senior Vice President, Controller, and Principal Accounting Officer, Layth Taki, earlier in November 2025. The company also revealed the completion of its share buyback program, retiring over 12% of outstanding shares since March 2023, which could impact future per-share...

Cleveland-Cliffs (CLF) recently shook up its boardroom by appointing Edilson Camara, a seasoned executive, as a director. This move comes at a time when the company is making renewed efforts to combat revenue and margin pressures related to soft selling prices. See our latest analysis for Cleveland-Cliffs. Cleveland-Cliffs has seen its share price stage a sharp comeback in recent sessions, bouncing over 9% in the past week after a tough 30-day stretch when shares dropped nearly 16%. While...

Intellia Therapeutics (NTLA) has been a stock in motion recently, catching investor attention after its latest quarterly performance numbers were released. The company posted strong annual revenue growth; however, losses remain a factor for this biotech name. See our latest analysis for Intellia Therapeutics. Despite the recent quarterly update providing a spark, Intellia Therapeutics' share price momentum tells a more cautionary tale. The company has experienced a 30-day share price return...

At the Stephens Annual Investment Conference held prior to today, Utz Brands presented its growth strategy, announcing plans for California expansion, a 16% margin target by 2026, and a focus on modernizing its supply chain through automation and AI tools. Utz's emphasis on outpacing the Salty Snacks category for nine consecutive quarters and its disciplined capital allocation approach, including debt reduction and potential share buybacks, stand out as key priorities for long-term growth...

Earlier this month, Telephone and Data Systems announced third quarter results, an expanded US$500 million share buyback program, and that Oaktree Capital Management acquired nearly 3.7 million shares for US$144.7 million. This renewed institutional interest follows the company’s restructuring and divestiture of its wireless business, with a sharper focus on fiber infrastructure and capital return initiatives. We’ll examine how the new share repurchase authorization may influence the...